Pharmaceutical Inspection Machines Market Size To Reach $1.62 Billion By 2030

Pharmaceutical Inspection Machines Market Growth & Trends

The global pharmaceutical inspection machines market is anticipated to reach USD 1.62 billion by 2030, growing at a CAGR of 9.9%, according to a report by Grand View Research, Inc. This growth trajectory is driven by several critical factors, including the increasing prevalence of chronic and complex diseases, stringent regulatory requirements, technological advancements, and expanding pharmaceutical outsourcing. As the industry evolves, stakeholders are increasingly investing in advanced inspection systems to ensure product quality, meet regulatory standards, and address the complexities of modern drug formulations.

The growing prevalence of chronic diseases and complex drug formulations significantly drives the demand for sophisticated inspection technologies. As treatments for conditions such as cancer, diabetes, and cardiovascular diseases evolve, there is a corresponding need for advanced inspection systems capable of handling new drug formulations and biologics. These include large molecules like monoclonal antibodies and gene therapies, which require high-precision inspection to ensure efficacy and safety.

Innovations in artificial intelligence (AI) and machine learning (ML) have transformed inspection systems, enhancing their accuracy and efficiency. AI-powered vision systems can now detect minute defects in real time with high resolution, which is crucial for complex drug formulations and biologics. For instance, integrating AI into inspection machines, such as those by Syntegon Technology, allows for real-time defect detection and higher detection rates, improving overall product quality and compliance.

 Request a free sample copy or view report summary: Pharmaceutical Inspection Machines Market Report

Pharmaceutical Inspection Machines Market Report Highlights

• Based on component, the inspection systems segment dominated the market with a substantial share of 76.0% in 2023 and is also expected to grow at the fastest CAGR of 10.2% during the forecast period. This segment's substantial market share and rapid growth can be attributed to the increasing complexity of pharmaceutical products, stringent regulatory requirements, and ongoing technological advancements.

• Based on type, the fully automated segment held the largest revenue share of more than 40.0% in 2023 and is also expected to grow at the fastest CAGR of 10.5% during the forecast period.  

• Based on formulation, the oral segment dominated the global market for pharmaceutical inspection machines in 2023, capturing a substantial revenue share and is also expected to growth at the fastest CAGR during the forecast period. This prominence is primarily driven by the high demand for oral medications and stringent regulatory standards.

• Based on end use, the syringes segment dominated the global market in 2023, capturing a substantial revenue share of 35.8%.

• CROs & CDMOs are anticipated to achieve the fastest CAGR of 10.2% during the forecast period.

Pharmaceutical Inspection Machines Market Segmentation

Grand View Research has segmented the global pharmaceutical inspection machines market report based on component, type, formulation, packaging, end-use and region:

Pharmaceutical Inspection Machines Component Outlook (Revenue, USD Million, 2018 - 2030)

• Inspection System

  • Vision Inspection System

    • Multifunctional

    • Specialized

  • Leak Detection System

  • Metal Detectors

  • X-ray Inspection System

  • Checkweighing System

  • Combination System

  • Others

• Software

Pharmaceutical Inspection Machines Type Outlook (Revenue, USD Million, 2018 - 2030)

• Semi-automated

• Fully-automated

• Manual

Pharmaceutical Inspection Machines Packaging Outlook (Revenue, USD Million, 2018 - 2030)

• Syringes

• Bottles

• Blisters

• Ampoules/Vials

• Others 

Pharmaceutical Inspection Machines Formulation Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

  • Tablets/Capsules

  • Oral Solutions/Syrups

  • Others

• Parenteral

• Others

Pharmaceutical Inspection Machines End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical Companies

• Biotechnology Companies

• CROs & CDMOs

Pharmaceutical Inspection Machines Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Pharmaceutical Inspection Machines Market

• Anritsu Corporation

• ACG Group

• ANTERAS VISION

• Cognex Corporation

• HEUFT Systemtechnik GmbH

• Ishida Co., Ltd.

• Körber AG

• Keyence Corporation

• Mettler-Toledo International Inc.

• Omron Corporation

• Optel Group

• Robert Bosch GmbH

• Sartorius AG

• Teledyne Technologies Incorporated

• Thermo Fisher Scientific Inc.